EMLA Topical Product — Competitive Intelligence Brief

EMLA Topical Product (EMLA Topical Product) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical local anesthetic. Area: Dermatology / Pain Management.

phase 3 Topical local anesthetic Voltage-gated sodium channels Dermatology / Pain Management Small molecule

Target snapshot

EMLA Topical Product (EMLA Topical Product) — American University of Beirut Medical Center. EMLA is a topical anesthetic cream containing lidocaine and prilocaine that blocks sodium channels in nerve fibers to produce local anesthesia and analgesia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
EMLA Topical Product TARGET	EMLA Topical Product	American University of Beirut Medical Center	phase 3	Topical local anesthetic	Voltage-gated sodium channels
Lamictal TM	Lamictal TM	Central Mental Clinic for Outpatients of Baku City	marketed	Anticonvulsant / Mood stabilizer	Voltage-gated sodium channels; glutamate release inhibition
Adjunctive Zonisamide	Adjunctive Zonisamide	Eisai Inc.	marketed	Anticonvulsant / Antiepileptic drug	Voltage-gated sodium channels, T-type calcium channels, carbonic anhydrase
Ropivacaine/Fentanyl	Ropivacaine/Fentanyl	National Institute for Tuberculosis and Lung Diseases, Poland	marketed	Local anesthetic with opioid analgesic combination	Voltage-gated sodium channels (ropivacaine); mu opioid receptor (fentanyl)
Levobupivacaine wound infiltration	Levobupivacaine wound infiltration	University of Genova	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Lidocaine-chlorprocaine combination	Lidocaine-chlorprocaine combination	Hadassah Medical Organization	marketed	Local anesthetic combination	Voltage-gated sodium channels
Scalp block with 0.5% plain Marcaine	Scalp block with 0.5% plain Marcaine	Chiang Mai University	marketed	Local anesthetic (amide)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical local anesthetic class)

1. American University of Beirut Medical Center · 1 drug in this class
2. Brown, Theodore R., M.D., MPH · 1 drug in this class
3. Eugene Y Rhee, MD · 1 drug in this class
4. IWK Health Centre · 1 drug in this class
5. The University of Texas Health Science Center, Houston · 1 drug in this class